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The effect of the oxidized form of neopterin (NP) on the NADPH-dependent superoxide-generating oxidase (NADPH-oxidase) was investigated 
in both whole-cell and cell-free activation systems by using peritoneal macrophages of rats which had received an intraperitoneal injection of mineral 
oil. In the whole-cell system, NP remarkably inhibited the generation of superoxides in macrophages timulated with phorbol myristate acetate 
(PMA). NP also showed an significant suppression of the activation of superoxide-generating NADPH-oxidase in the cell-free system using 
solubilized membranes and sodium dodecyl sulfate (SDS) as a stimulant. The 50%-inhibitory concentration (IC,,) of NP was about 1 PM in both 
assay systems. In a kinetic study, competitive inhibition of the NADPH-oxidase by NP was observed in the cell-free system with a calculated 
inhibition constant (4) of 6.50 PM. These findings suggest hat NP may play an important role in the suppression of superoxide generation via 
the inhibition of the NADPH-oxidase in phagocytes. 
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1. INTRODUCTION 
Neopterin (NP) is an a-amino-hydroxypteridine de- 
rivative, and a precursor of biopterin (BP), which is 
derived from guanosine triphosphate (GTP) [l]. 
Namely, intracellular GTP is cleaved by GTP-cy- 
clohydrolase to 7,8-dihydroneopterin triphosphate 
(NPH2TP). This compound is further converted into 
tetrahydrobiopterin (BPH4) by the actions of two en- 
zymes, 6-pyruvoyltetrahydropterin synthase and se- 
piapterin reductase, in succession. This pathway has 
been established in liver, neuroendocrine tissues, and 
lymphocytes [2]. Human monocytes/macrophages, 
however, lack 6-pyruvoyltetrahydropterin synthase. As 
a consequence, these cells accumulate NPH2TP and 
excrete 7,8-dihydroneopterin (NPH2) and NP after 
cleavage of the phosphate moiety by phosphatase. It has 
been generally accepted that NP is released from mon- 
ocytes/macrophages, that interferon-y (IFN-y), one of 
the immuno-modulators produced by activated T cells, 
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is the only inducer for NP secretion from macrophages 
[3,4], and that IFN-)I increases the intracellular concen- 
tration of GTP as well as the conversion of it to NP [5]. 
Although the biological function of NP remains un- 
known, NP is used as a clinical marker for the diagnosis 
of patients with various malignant disorders, as well as 
viral infections including AIDS [6-g]. 
On the other hand, active oxygen species such as 
superoxide anion radicals have recently been suggested 
to be potent pathogenic factors in various viral diseases, 
so that the pathogenesis may involve no direct viral 
cytotoxicity, but reactivity of active oxygen species re- 
leased by lymphocytes [lO,l 11. That is, an excess 
amount of active oxygen species following overreaction 
of the immunodefense response against the virus-in- 
fected organs, may participate in the mechanism of tis- 
sue injuries observed in various types of viral diseases. 
Based on these reports, we suspected that NP might 
play an important role as an endogenous cavenger of 
active oxygen species in these viral diseases. In previous 
reports, we have demonstrated potent antioxidant activ- 
ities of pteridines, particularly the reduced form of NP, 
i.e. 5,6,7,8-tetrahydroneopterin (NPH4) [12-141. Re- 
cently, the antioxidant potency of the reduced form of 
pteridines has also been confirmed by Weiss et al. [15]. 
Our investigations have made it clear that NPH4 di- 
rectly reacts with the released superoxide anion radicals 
in both phagocytelphorbol myristate acetate (PMA) 
and xanthine/xanthine oxidase (X/XOD) reaction sys- 
tems. On the other hand, NP, an oxidized form of 
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neopterin, shows potent antioxidant activity in the 
phagocyte/PMA-superoxide reaction system, but not in 
the X/XOD superoxide reaction system. Those previous 
findings indicated that NP might inhibit the process of 
superoxide generation in phagocytes. 
In order to elucidate the mechanism of the inhibitory 
effect of NP on superoxide generation in phagocytes, 
the effect of NP on the NADPH-dependent superoxide- 
generating oxidase was investigated in rat peritoneal 
macrophages, since superoxide radicals are produced 
primarily through the activation of plasma membrane- 
bound NADPH oxidase (EC1.6.99.6) in phagocytes, 
such as lymphocytes and macrophages, upon stimula- 
tion with various agents, such as concanavalin A, PMA, 
phospholipase C, endotoxin and detergents. 
2. MATERIALS AND METHODS 
2.1. Reagents 
Cytochrome c from horse heart,B-NADPH (type I), phorbol myris- 
tate acetate (PMA), erythrocyte Cu, Zn-superoxide dismutase (SOD) 
(3,300 Ulmg protein, grade IV), Hanks’ balanced salt solution 
(HBSS), Percoll, and o-neopterin (NP) were purchased from Sigma 
Chemicals Co., Ltd (St. Louis, MO). 5,6,7,8_Tetrahydroneopterin 
(NPW) was from Junsei Chemicals Co., Ltd. ATP, sodium deoxycho- 
late, dimethyl sulfoxide (DMSO), EGTA, flavin adenine dinucleotide 
(FAD), glycerol, sucrose, sodium dodecyl sulfate (SDS), and PIPES 
were obtained from Wako Chemicals Co., Ltd. (Tokyo, Japan). So- 
dium deoxycholate was recrystallized from ethanol before use. All 
other chemicals used were of the highest purity grade available from 
commercial sources. 
2.2. Cell preparation and subfractionation 
Rats were injected intraperitoneally with 10 ml of mineral oil and 
exudates were harvested 5 days later. The cells were washed 3 times 
with HBSS by centrifugation at 350 x g for 5 min. Erythrocytes were 
eliminated by hypotonic lysis. The cells suspension contained more 
than 90% macrophages. 
2.3. Solubilization of membranes and preparation of cytosol 
Solubilization of the membranes and preparation of the cytosol 
were basically done by the method of Umeki [16], with a slight mod- 
ification. Briefly, cells were disrupted and homogenized by using a 
sonicator fitted with a titanium probe. The homogenate was freed of 
unbroken cells, nuclei, and large debris by centrifugation of 800 x g 
for 10 min at 4°C and the supernatant was subjected to subcellular 
fractionation. It was centrifuged at 48,000 x g for 1 hr at 4°C in a 
fixed-angle rotor (SRP 7OAT-230) of a Hitachi ultracentrifuge 
(SCP85H2). The pellet was resuspended in ice-cold phosphate-buff- 
ered saline (PBS)-sucrose buffer which was composed of 131 mM 
NaCl, 8 mM Na,K-phosphate buffer, pH 7, and 340 mM sucrose, to 
the original volume of the homogenate by sonication for 3 s and 
subjected to stepwise Percoll gradient fractionation [17]. The mem- 
branes were obtained by pooling the y-fraction (230,000 x g for 2 h 
at 4°C). The pooled membranes were suspended at a concentration 
of 3 x lo* cells eq/ml in half-strength Borregaard’s relaxation buffer, 
which contains 50 mM KC1 1.5 mM NaCl, 5 mM PIPES, pH 7.3, 1.75 
mM MgCl,, 0.5 mM ATP, 0.62 mM EGTA, and 0.34 M sucrose. The 
suspension was divided into aliquots and stored at -70°C. The mem- 
brane suspension was thawed at room temperature, mixed with an 
equal volume of extraction buffer containing 1 mM NaN,, 0.0017 mM 
CaCl,, 20 mM sodium glycinate (pH 8.0), 2.33% sodium deoxycholate 
(w/v), and 50% glycerol (v/v). vortexed briefly, incubated on ice for 30 
mm with occasional agitation, and finally centrifuged at 435,000 x g 
for 1 h at 4°C. The supematant from the 230,000 x g spin was also 
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divided into aliquots and stored at -70°C. This material served as the 
source of cytosolic activation factor. Protein content was assayed in 
macrophage homogenates and subcellular fractions by the methods of 
Lowry et al. [18]. 
2.4. Assay of NADPH-dependent superoxide production 
Superoxide production by intact PMA-stimulated macrophages 
(whole-cell system) was assayed by a discontinuous method in which 
the SOD-inhibitable reduction of cytochrome c was monitored by 
absorbance measurement. That is, 2 x 10’ cells were preincubated in 
an HBSS assay medium containing 0.12 mM cytochrome c and the 
desired concentration of NP for 2 min at 37°C before the reaction was 
started by adding PMA (0.3 &ml in DMSO). Assay mixtures were 
incubated for 4 min at 37’C, in a total volume of 1.0 ml. The reference 
cuvette contained 20 pg of SOD in addition to these components. 
Superoxide production in the cell-free system was assayed by the 
method of Cumutte et al. [19] with a slight modification. The assay 
mixture contained 0.1 mM cytochrome c, 3.6 mM MgCl,, 89 mM KCl, 
2.7mMNaCl,0.5mMPIPES(pH7.3),0.9mMATP, 1.2mMEGTA, 
0.5 PM FAD, 6 x lo6 cells eq of cytosol, 1.5 x lo6 cells eq of mem- 
branes solubilized in deoxycholate, the desired concentration of NP, 
0.04 mM SDS and 0.16 mM NADPH in a total volume of 0.75 ml. 
The reaction mixture except for NADPH was preincubated for 2 min 
at 37°C. Then the reaction was started by adding NADPH and the 
change in absorbance at 550 nm was followed for 3 min on a Hitachi 
320 double-beam spectrophotometer. The reference cuvette contained 
40 pug of SOD. In kinetic studies, concentrations of NADPH were 
varied in the cell-free system. The initial rate of superoxide production 
was calculated from the linear segment of the increase in absorbance 
at 550 nm and translated into nanomoles of super-oxide by using an 
extinction coefficient of E = 19.6 mM-‘cm-‘. 
3. RESULTS AND DISCUSSION 
Our previous study on the scavenging activity of 
pteridines against superoxide anion radicals had shown 
that the oxidized form of neopterin (NP) exhibits potent 
antioxidant activity in the splenic macrophage/PMA- 
superoxide generation system, though it has little effect 
in the X/XOD reaction system. Namely, the 50% inhib- 
itory concentration (IC,,) of NP was about 1.0 PM in 
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Fig. 1. Dose-dependent inhibition by NP of superoxide generation in 
intact rat macrophages timulated with PMA. The assay method is 
described in section 2. Concentration of 1 to 10pM of neopterins were 
used in the assays. Each value represents the mean f S.D. of three 
independent assays. 
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Fig. 2. Dose-dependent inhibition by NP of superoxide generation in 
the cell-free system. The assay method is described in section 2. Con- 
centrations of 1 to 10 PM NP were used in the assays. Each value 
represents the mean f SD. of three independent assays. 
the splenic macrophage/PMA reaction system, but 
more than 370 ,uM in the X/XOD reaction system [12]. 
These findings led us to speculate that NP interfered 
with the process of generation of the superoxide in ph- 
agocytes. In order to elucidate the antioxidant mecha- 
nism of NP in the macrophage/PMA reaction system, 
we investigated the effect of NP on rat peritoneal mac- 
rophage NADPH-oxidase activity. 
As shown in Fig. I, NP significantly inhibited the 
superoxide generation in the intact macrophage/PMA 
reaction system (whole-cell system) in a dose-dependent 
manner. The I&, for NP was 1.39 PM and this value 
is in good agreement with those we previously obtained 
in the mouse splenic macrophage/PMA reaction system. 
In this whole-cell system, NP may enter into the cells 
through the membrane, and be intracellularly reduced 
to NPH2 or NPH4, which has potent antioxidant activ- 
h 0 
7 
NP(OflM) 
E . NP (O.’ lJw g 6 - 
A NP(lO@) 
n NP(lOfl) 
5 
‘r 
$ 
D&I 
0 
5 
E 
s 
3 
-2 0 2 4 
lI[NADPH] {lo0 x ~.LM -3
Fig. 3. Lineweaver-Burk plot of NADPH-oxidase-dependent super- 
oxide generation by SDS-activated rat macrophage sonicates. The 
mean values of 3 independent assays are shown. 
ity as previously reported [12,15], and these reduced 
forms of NP may directly scavenge the superoxides. 
However, if that is the case, the activity should be much 
stronger (close to that of NPH4) in this assay system. 
Elevation of the cytosol calcium concentration has 
also been considered to be an important factor for su- 
peroxide generation in phagocytes. Recently, it has been 
demonstrated that pteridine derivatives such as NP in- 
crease intracellular calcium concentration in human 
monocytes, and it was suggested that they are involved 
in the regulation of calcium-mediat-ed macrophage ac- 
tivation including superoxide generation [20]. Another 
important factor for the superoxide generation is pro- 
tein kinase C (PKC). In the phagocytic cells/PMA su- 
peroxide generation system, PKC has been considered 
to be a receptor of and to be activated by PMA, which 
also activates the respiratory burst [21]. We also prelim- 
inarily examined the effect of NP on PKC activity in the 
rat peritoneal macrophage. NP did not show any effect 
on the PKC activity over the range of concentration 
which effectively inhibited superoxide generation. In 
order to examined the mechanism of the NP action, we 
examined the inhibitory effect of NP on the NADPH- 
oxidase using a cell-free system. As shown in Fig. 2, NP 
significantly inhibited the generation of the superoxides 
(I&, of 1.23 ,uM). This value is almost the same as that 
in the intact whole-cell system. Since it is unlikely that 
NPH2 or NPH4 is formed from NP in this cell-free 
system, the inhibitory effect appears to be due to a direct 
effect of NP on NADPH-oxidase itself. To better under- 
stand the effect of NP on the activation of NADPH- 
oxidase in the cell-free system, we examined the inhibi- 
tion at various concentrations of NP or NADPH. Fig. 
3 shows a Lineweaver-Burk plot of the inhibition of the 
NADPH-oxidase by NP. The inhibition was competi- 
tive with respect o NADPH. The values of K,.,, and V,,, 
were 42.64 ,uM and 0.74 nmol O,-/mg protein/min. The 
apparent K, for NP was 6.50 PM. We also noted inhib- 
itory effects of oxidized and reduced forms of other 
pteridine derivatives, including BP, pterin, etc. (unpub- 
lished data). These findings suggest hat pterdine deriv- 
atives may be important suppressive factors of the pro- 
duction of superoxide in phagocytes. Detailed studies 
on the mechanisms involved are under way. 
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